Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ascension Ventures
BioCentury | Mar 29, 2022
Data Byte
Three radiotherapy companies have raised over $200M in 1Q22
March fund-raisings equate to over 80% of 2021’s total venture capital raised and almost two-thirds of 2020’s total
BioCentury | Mar 11, 2022
Deals
March 10 Quick Takes: Scenic heads to clinic with $31M series A
Plus AbbVie, Venatorx meet in Phase III and updates from MorphoSys, RefleXion, TG Therapeutics, Xeris and more
Items per page:
1 - 4 of 4